Umeclidinium Bromide News
Umeclidinium Bromide currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Umeclidinium Bromide with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Rolufta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
- Evidence level: L5
- Predicted indications (20):
- migraine disorder (96.4%)
- migraine with brainstem aura (95.8%)
- open-angle glaucoma (93.3%)
- primary hereditary glaucoma (92.9%)
- nephrogenic syndrome of inappropriate antidiuresis (92.0%)
- gastroduodenitis (91.9%)
- common cold (91.7%)
- atrophoderma vermiculata (91.2%)
- peptic ulcer disease (91.0%)
- allergic urticaria (90.7%)
- migraine with or without aura, susceptibility to (90.6%)
- ulerythema ophryogenesis (89.8%)
- schizophrenia (89.8%)
- Ambras type hypertrichosis universalis congenita (89.8%)
- hypertrichosis (disease) (89.5%)
- insomnia (disease) (89.5%)
- headache disorder (89.4%)
- acute intermittent porphyria (89.4%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (89.1%)
- malformation syndrome with odontal and/or periodontal component (89.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.